BlackRock Fund Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$109M Buy
4,391,858
+2,294,203
+109% +$52.1M 0.02% 1137
2016
Q3
$47.3M Buy
2,097,655
+79,811
+4% +$1.88M 0.01% 1614
2016
Q2
$48.1M Buy
2,017,844
+152,317
+8% +$3.65M 0.01% 1523
2016
Q1
$44.3M Sell
1,865,527
-27,471
-1% -$672K 0.01% 1525
2015
Q4
$52.7M Buy
1,892,998
+90,304
+5% +$2.27M 0.01% 1438
2015
Q3
$37.2M Sell
1,802,694
-59,059
-3% -$1.5M 0.01% 1604
2015
Q2
$47.8M Sell
1,861,753
-18,319
-1% -$464K 0.01% 1559
2015
Q1
$47.5M Buy
1,880,072
+19,001
+1% +$463K 0.01% 1538
2014
Q4
$44.2M Buy
1,861,071
+258,902
+16% +$5.73M 0.01% 1542
2014
Q3
$31.5M Sell
1,602,169
-23,621
-1% -$486K 0.01% 1662
2014
Q2
$38.9M Buy
1,625,790
+120,626
+8% +$2.91M 0.01% 1566
2014
Q1
$40M Buy
1,505,164
+56,849
+4% +$1.35M 0.01% 1554
2013
Q4
$29.2M Sell
1,448,315
-244,314
-14% -$4.54M 0.01% 1765
2013
Q3
$29.6M Buy
1,692,629
+453,411
+37% +$7.85M 0.01% 1709
2013
Q2
$20.9M Buy
+1,239,218
New +$19.1M 0.01% 1830

Other funds holding GMED

BlackRock Fund Advisors's GMED Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Globus Medical (GMED) stake by 109% in Q4 2016, buying an estimated $52.1M and bringing the position to 4,391,858 shares worth $109M. The position accounts for 0.02% of the portfolio, ranked #1137.

BlackRock Fund Advisors first reported a position in GMED in Q2 2013 and has held it in 15 quarters since. 207 funds tracked by Wall St. Rank hold GMED as of Q4 2016.

  • BlackRock Fund Advisors held 4,391,858 shares of Globus Medical worth $109M as of Q4 2016.
  • BlackRock Fund Advisors bought 2,294,203 Globus Medical shares in Q4 2016, an estimated $52.1M.
  • Globus Medical made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1137 holding.
  • BlackRock Fund Advisors first reported a position in Globus Medical in Q2 2013 and has held it in 15 quarters since.
  • 207 funds tracked by Wall St. Rank held Globus Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.